OGGIONI, NORBERTO
 Distribuzione geografica
Continente #
NA - Nord America 14.181
AS - Asia 8.410
EU - Europa 6.605
SA - Sud America 1.062
AF - Africa 194
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 22
Totale 30.518
Nazione #
US - Stati Uniti d'America 13.360
SG - Singapore 3.252
CN - Cina 1.826
IT - Italia 1.200
DE - Germania 1.082
HK - Hong Kong 1.033
RU - Federazione Russa 932
VN - Vietnam 885
SE - Svezia 865
BR - Brasile 783
CA - Canada 706
IE - Irlanda 666
UA - Ucraina 561
GB - Regno Unito 376
FR - Francia 291
IN - India 266
BD - Bangladesh 190
KR - Corea 184
FI - Finlandia 170
AT - Austria 117
ID - Indonesia 108
AR - Argentina 106
TR - Turchia 96
JP - Giappone 88
IQ - Iraq 75
DK - Danimarca 69
ZA - Sudafrica 69
MX - Messico 65
NL - Olanda 56
ES - Italia 53
PK - Pakistan 53
PL - Polonia 47
MY - Malesia 46
SA - Arabia Saudita 42
PH - Filippine 41
CO - Colombia 35
EC - Ecuador 35
VE - Venezuela 31
IR - Iran 27
BE - Belgio 22
CL - Cile 22
AU - Australia 21
PY - Paraguay 20
UZ - Uzbekistan 20
EG - Egitto 19
MA - Marocco 19
NZ - Nuova Zelanda 19
ET - Etiopia 18
EU - Europa 18
KZ - Kazakistan 18
TH - Thailandia 18
AE - Emirati Arabi Uniti 17
KE - Kenya 17
LT - Lituania 17
TN - Tunisia 17
JO - Giordania 16
NP - Nepal 16
CH - Svizzera 14
UY - Uruguay 14
AZ - Azerbaigian 11
OM - Oman 11
IL - Israele 10
CZ - Repubblica Ceca 9
PE - Perù 9
PS - Palestinian Territory 9
JM - Giamaica 8
AL - Albania 7
BG - Bulgaria 7
BH - Bahrain 7
KG - Kirghizistan 7
LB - Libano 7
AO - Angola 6
BO - Bolivia 6
CR - Costa Rica 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
NG - Nigeria 6
PA - Panama 6
RS - Serbia 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
DZ - Algeria 5
GE - Georgia 5
HN - Honduras 5
HR - Croazia 5
MD - Moldavia 4
RO - Romania 4
SN - Senegal 4
SY - Repubblica araba siriana 4
BY - Bielorussia 3
GT - Guatemala 3
KW - Kuwait 3
MM - Myanmar 3
NI - Nicaragua 3
NO - Norvegia 3
PT - Portogallo 3
A1 - Anonimo 2
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
BZ - Belize 2
Totale 30.476
Città #
Singapore 2.040
Ann Arbor 1.879
Ashburn 1.123
Hong Kong 987
San Jose 939
Woodbridge 819
Chandler 689
Dublin 644
Jacksonville 550
Houston 540
Toronto 494
Frankfurt am Main 484
Milan 469
Fairfield 456
Wilmington 448
Dearborn 424
New York 351
Dallas 345
Santa Clara 279
Beijing 269
Ho Chi Minh City 248
Los Angeles 248
Princeton 244
Boardman 218
Chicago 217
The Dalles 197
Hanoi 185
Seattle 183
Nanjing 178
Council Bluffs 160
Cambridge 138
Shanghai 134
Seoul 129
Hefei 119
Vienna 111
Lauterbourg 108
Rome 101
Buffalo 93
Lachine 89
Dong Ket 78
Guangzhou 78
Jakarta 74
Moscow 74
Altamura 73
Lawrence 73
Orem 67
Nanchang 59
São Paulo 58
Munich 54
Helsinki 51
Fremont 45
Shenyang 44
Andover 42
Tokyo 41
Columbus 40
Grafing 40
Jinan 40
Zhengzhou 37
Da Nang 36
Jiaxing 36
Brooklyn 34
Johannesburg 34
Denver 33
Montreal 33
Nürnberg 33
San Diego 33
Atlanta 32
Tianjin 32
Baghdad 31
Changsha 31
Chennai 31
Phoenix 31
Rio de Janeiro 30
London 29
Pune 29
Ottawa 27
Falls Church 26
Daejeon 24
Haiphong 24
Hangzhou 24
Kunming 24
Ankara 23
Mountain View 23
Philadelphia 23
Warsaw 23
Hebei 22
Nuremberg 22
Basingstoke 21
Brussels 21
Istanbul 21
Sacramento 21
Boston 20
San Francisco 20
Stockholm 20
Tashkent 20
Dhaka 19
Turku 19
Addis Ababa 18
Figino 18
Lahore 17
Totale 19.485
Nome #
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 504
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 465
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 439
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 434
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 431
Age-related changes in the function and structure of the peripheral sensory pathway in mice 424
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 414
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 412
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 402
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 395
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 383
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 381
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 359
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 339
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 330
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 327
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 325
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 324
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 319
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 317
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 317
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 313
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 308
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 304
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 304
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 299
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 299
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 297
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 297
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 295
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 295
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 294
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 292
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 291
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 286
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 283
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 276
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 274
Effect of proteasome inhibition on the central and peripheral nervous system 272
Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor 271
Multimodal experimental approach to the study of human neurological diseases 268
Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration 267
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 261
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 259
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 259
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 257
Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis 257
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 256
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 255
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 254
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 253
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 252
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis 251
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 250
Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis 250
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 249
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 249
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 248
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 248
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 248
Lipoplatin tm: a less neurotoxic formulation of cisplatin 247
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 246
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 245
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis 245
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 245
Granulocytes in actively induced Lewis rat EAE 240
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 238
Effects of palmitoylethanolamide (pea) in cisplatin-induced peripheral neuropathy in mice. 237
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 237
Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats 236
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 236
Erythropoietin both protects from and reverses experimental diabetic neuropathy 234
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 232
Characterization of spleen and spinal cord infiltrating lymphocytes during actively induced EAE in Lewis rats. 231
The new analgesic CR4056 effectively abrogates neuropathic pain induced by Bortezomib in rats 231
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 229
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 225
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 224
Neurotoxicity and neuropatic pain induced by Bortezomib:evaluation of peripheral nerve fibres from a clinical to an ultrastructural level 223
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 222
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 220
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 216
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 215
Regression of diabetic complications by islet transplantation in the rat 211
Cisplatin-induced painful peripheral neuropathy severity is strain-dipendent in mice: dissecting the role of pharmacogenomics. 211
Actively induced EAE in Lewis rats: Characterization of spleen and spinal cord infiltrating lymphocytes by flow cytometry during the course of the disease 210
Peripheral neuropathy induced by chronic administration of cisplatin, taxol and bortezomib in several murine models 207
Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis 206
Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy 206
L-serine supplementation suppresses the formation of neurotoxic deoxysphingolipids and improves neuropathy in a type 1 diabetic rat model 206
STUDY OF THE CALCITONIN GENE-RELATED PEPTIDE-POSITIVE INTRAEPIDERMAL NERVE FIBERS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY 206
Biodistrubution and toxicology of two PFCs intravenously injected in rats 206
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 206
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 201
Neurotoxicity ad neuropathic pain induced by Bortezomib: evaluation of peripheral nerve fibres from a clinical to an ultrastructural level. 201
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 200
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats 197
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 194
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 192
Chemotherapy-induced peripheral neuropathy in immunodeficient mice: new useful ready-to-use animal models 192
Totale 27.488
Categoria #
all - tutte 95.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.123


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.395 81 139 137 127 96 142 65 76 57 116 102 257
2022/20232.631 297 726 232 255 192 426 34 137 210 30 51 41
2023/20242.006 64 61 78 64 274 525 348 89 99 40 23 341
2024/20254.437 280 601 354 206 345 118 203 166 470 609 406 679
2025/202611.688 1.130 676 905 918 1.166 739 1.865 606 996 998 781 908
2026/202798 98 0 0 0 0 0 0 0 0 0 0 0
Totale 31.421